Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity

INTRODUCTION: Infliximab is a chimeric monoclonal antibody against tumor necrosis factor alpha (TNF-α) that has been introduced recently for Behçet's disease (BD) patients who were resistant to standard treatment. The aim of this study was to analyse the functional changes of Vγ9/Vδ2 T lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Accardo-Palumbo, Antonina, Giardina, Anna Rita, Ciccia, Francesco, Ferrante, Angelo, Principato, Alfonso, Impastato, Rosalia, Giardina, Ennio, Triolo, Giovanni
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911900/
https://www.ncbi.nlm.nih.gov/pubmed/20525258
http://dx.doi.org/10.1186/ar3043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911900/
https://www.ncbi.nlm.nih.gov/pubmed/20525258
http://dx.doi.org/10.1186/ar3043

Ejemplares similares